Turkina, A. G., and Elena Andreevna Kuzmina. 2024. “Treatment Outcomes With Asciminib, the First Allosteric BCR::ABL1 Tyrosine Kinase Inhibitor, in Chronic Myeloid Leukemia Patients With Multiple Resistance to Prior Therapy”. Clinical Oncohematology 16 (3): 311-20. https://doi.org/10.21320/2500-2139-2023-16-3-311-320.